New Key Statistics Module, Z-Score and F-Score
OTCPK:HNSBF Key Ratios
| Market Cap $ M | 240.18 |
| Enterprise Value $ M | 254.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 11.42 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 18.00 |
| EPS (TTM) $ | -1.09 |
| Beneish M-Score | -1.29 |
| 10-y EBITDA Growth Rate % | -34.60 |
| 5-y EBITDA Growth Rate % | -15.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.07 |
| EV-to-EBITDA | -5.07 |
| PEG | -- |
| Shares Outstanding M | 65.61 |
| Net Margin (%) | -345.73 |
| Operating Margin % | -338.93 |
| Pre-tax Margin (%) | -345.51 |
| Quick Ratio | 2.44 |
| Current Ratio | 2.45 |
| ROA % (ttm) | -65.61 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -144.18 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.03 |
HNSBF Number of Guru Trades
HNSBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:HNSBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:HNSBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hansa Biopharma AB Insider Transactions
No Available Data
News about OTCPK:HNSBF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers